JP2008512445A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512445A5
JP2008512445A5 JP2007530849A JP2007530849A JP2008512445A5 JP 2008512445 A5 JP2008512445 A5 JP 2008512445A5 JP 2007530849 A JP2007530849 A JP 2007530849A JP 2007530849 A JP2007530849 A JP 2007530849A JP 2008512445 A5 JP2008512445 A5 JP 2008512445A5
Authority
JP
Japan
Prior art keywords
derivative
liposome
pharmaceutical composition
composition according
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512445A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2005/000962 external-priority patent/WO2006027786A2/en
Publication of JP2008512445A publication Critical patent/JP2008512445A/ja
Publication of JP2008512445A5 publication Critical patent/JP2008512445A5/ja
Pending legal-status Critical Current

Links

JP2007530849A 2004-09-09 2005-09-11 炎症状態の治療のためのリポソーム性グルココルチコイドの使用 Pending JP2008512445A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60814004P 2004-09-09 2004-09-09
PCT/IL2005/000962 WO2006027786A2 (en) 2004-09-09 2005-09-11 Use of liposomal glucocorticoids for treating inflammatory states

Publications (2)

Publication Number Publication Date
JP2008512445A JP2008512445A (ja) 2008-04-24
JP2008512445A5 true JP2008512445A5 (https=) 2008-10-30

Family

ID=35432741

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007530850A Expired - Fee Related JP5355890B2 (ja) 2004-09-09 2005-09-11 グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
JP2007530849A Pending JP2008512445A (ja) 2004-09-09 2005-09-11 炎症状態の治療のためのリポソーム性グルココルチコイドの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007530850A Expired - Fee Related JP5355890B2 (ja) 2004-09-09 2005-09-11 グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物

Country Status (7)

Country Link
US (3) US7744920B2 (https=)
EP (2) EP1793804A2 (https=)
JP (2) JP5355890B2 (https=)
CN (2) CN101043875B (https=)
AU (2) AU2005281352B2 (https=)
CA (2) CA2579786A1 (https=)
WO (2) WO2006027787A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
WO2004096140A2 (en) 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US7744920B2 (en) * 2004-09-09 2010-06-29 Hadasit Medical Research Services & Development Limited Use of liposomal glucocorticoids for treating inflammatory states
DE102007060199A1 (de) 2007-12-14 2009-06-18 Osram Gesellschaft mit beschränkter Haftung Leuchtstoff und Beleuchtungssystem mit derartigem Leuchtstoff
DE102007060198A1 (de) 2007-12-14 2009-06-18 Osram Gesellschaft mit beschränkter Haftung Konversions-LED
EP3415151A1 (en) * 2008-05-23 2018-12-19 The University of British Columbia Modified drugs for use in liposomal nanoparticles
EP2127639A1 (en) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid containing liposomes for treatment of cardiovascular diseases
CN101601652B (zh) * 2008-06-11 2012-07-04 天津金耀集团有限公司 糠酸莫米松脂质体乳膏
CA2752373C (en) * 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
US20130052259A1 (en) * 2010-02-01 2013-02-28 Yechezkel Barenholz Liposomes comprising amphipathic drugs and method for their preparation
JP2011246464A (ja) * 2010-04-28 2011-12-08 Wakamoto Pharmaceutical Co Ltd ジクロフェナクナトリウムを封入した後眼部到達用ポリマーコーティングリポソーム
WO2012094033A1 (en) 2011-01-05 2012-07-12 Livon Laboratories Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
EP3069785A1 (en) 2011-10-25 2016-09-21 The University Of British Columbia Limit size lipid nanoparticles and related methods
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
RU2677658C2 (ru) 2012-07-05 2019-01-18 Тайвэн Липосом Ко, Лтд. Способы лечения артрита
CN103083239B (zh) * 2012-12-26 2015-11-25 中国人民解放军第四军医大学 一种蟾毒灵脂质体及其制备方法和应用
CA2906732C (en) 2013-03-15 2023-08-08 The University Of British Columbia Lipid nanoparticles for transfection and related methods
JP6151786B2 (ja) * 2013-09-30 2017-06-21 富士フイルム株式会社 医療支援装置、医療支援装置の制御方法、医療支援プログラム及び医療支援システム
US20150132369A1 (en) * 2013-11-09 2015-05-14 Exir Nano Sina Company Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof
CN103720658B (zh) * 2014-01-07 2015-10-07 中国药科大学 肝素修饰的阿霉素脂质体制剂及其制备方法
SG11201805101RA (en) * 2015-12-17 2018-07-30 Univ Nanyang Tech Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them
TWI754659B (zh) * 2016-08-08 2022-02-11 台灣微脂體股份有限公司 用於製備含有弱酸性劑之微脂體組合物的傳輸載體、方法及套組
EP3658134A4 (en) 2017-07-24 2021-05-05 Pharmosa Biopharm Inc. LIPOSOME COMPOSITIONS WITH WEAK ACID MEDICINAL PRODUCTS AND USES THEREOF
EP3676402B1 (en) * 2017-08-30 2023-12-27 Bristol-Myers Squibb Company A method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids
MX2020011323A (es) 2018-05-07 2020-11-18 Pharmosa Biopharm Inc Composicion farmaceutica para liberacion controlada de treprostinil.
JP7482487B2 (ja) * 2018-09-13 2024-05-14 タイワン リポソーム カンパニー リミテッド 鎮静薬を含む徐放性医薬組成物およびその使用
MX2021001820A (es) * 2018-09-14 2021-04-28 Pharmosa Biopharm Inc Composicion farmaceutica para la liberacion controlada de farmacos acidos debiles y usos de los mismos.
KR102164260B1 (ko) * 2018-10-30 2020-10-12 (주)유에이치에이 메틸프레드니솔론 및 줄기세포를 유효성분으로 포함하는 다발성 경화증의 예방 또는 치료용 조성물
CN113827738B (zh) * 2020-06-08 2024-04-09 沈阳药科大学 唾液酸修饰地塞米松棕榈酸酯脂质体及其制备和应用
CN116077465B (zh) * 2022-02-25 2024-05-24 中南大学湘雅医院 用于关节镇痛的纳米制剂及其制备方法和应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56161317A (en) 1980-05-15 1981-12-11 Green Cross Corp:The Pharmaceutical preparation of fatty corpuscle of steroid
US4757056A (en) * 1984-03-05 1988-07-12 Hepar Industries, Inc. Method for tumor regression in rats, mice and hamsters using hexuronyl hexosaminoglycan-containing compositions
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5189018A (en) * 1991-08-19 1993-02-23 Wayne State University Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
US5817856A (en) * 1995-12-11 1998-10-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiation-protective phospholipid and method
DE19607722A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Dr Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung
CA2263455C (en) 1996-08-23 2002-10-29 Sequus Pharmaceuticals, Inc. Liposomes containing a cisplatin compound
EP0932390A1 (en) * 1996-10-11 1999-08-04 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US20030185826A1 (en) * 1999-02-24 2003-10-02 Tobinick Edward L. Cytokine antagonists for the treatment of localized disorders
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
CA2430897C (en) 2000-12-07 2010-11-16 Universiteit Utrecht Holding B.V. Liposomal composition comprising water-soluble corticosteroids for the treatment of inflammatory disorders
CA2437578A1 (en) * 2001-02-13 2002-08-22 Rivka Cohen Carotenoid-loaded liposomes
EP1413192B1 (en) 2001-07-11 2014-04-30 Max Co., Ltd. Binding machine for gardening
IL160350A0 (en) * 2001-09-06 2004-07-25 Yissum Res Dev Co A method for preparing liposome formulations with a predefined release profile
US20040219201A1 (en) * 2001-12-06 2004-11-04 Yechezkel Barenholz Tempamine compositions and methods of use
AU2003259028A1 (en) * 2002-06-10 2003-12-22 Combinatorx, Incorporated Combinations for the treatment of rheumatoid arthritis
EP1371362A1 (en) * 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
WO2004004640A2 (en) * 2002-07-05 2004-01-15 Tetragrammaton Inc. Methods, compositions and kits for treating damage to excitable tissue
EP1393720A1 (en) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US20060025446A1 (en) * 2004-07-27 2006-02-02 Jeffrey Sterling Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
US7744920B2 (en) * 2004-09-09 2010-06-29 Hadasit Medical Research Services & Development Limited Use of liposomal glucocorticoids for treating inflammatory states
DK2308514T3 (da) * 2007-03-23 2013-09-02 To Bbb Holding B V Konjugater til målrettet lægemiddeltransport gennem blod-hjerne barrieren

Similar Documents

Publication Publication Date Title
JP2008512445A5 (https=)
JP2008512446A5 (https=)
JP5355890B2 (ja) グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
RU2468797C2 (ru) Способ и композиция для лечения воспалительных нарушений
ES2498795T3 (es) Composición de liposomas que contienen antihistamínicos y corticosteroides y su uso para la fabricación de un medicamento para tratar la rinitis y trastornos relacionados
JP5645340B2 (ja) 活性成分を含有するカチオンリポソームの投与方法
JP4869594B2 (ja) 癌治療のための小胞封入コルチコステロイド
ES2875742T3 (es) Métodos para aumentar la inhibición tónica y tratamiento del síndrome de Angelman
JP2014532697A (ja) ヒトにおける炎症性障害の治療用リポソームコルチコステロイド
JP4623931B2 (ja) 炎症性疾患の治療用組成物
JP2006509750A5 (https=)
JP2004509854A (ja) バルプロ酸のリン脂質誘導体およびそれらの混合物
JP2008512444A (ja) 神経変性状態の治療のための、両親媒性弱塩基様テンパミンを含むリポソーム製剤
JP2016050181A (ja) 血管炎治療剤
TWI857961B (zh) 減少關節內類固醇的併發症之方法
JPWO2017222042A1 (ja) 眼用医薬組成物
JP2018517736A (ja) 炎症性疾患又は病態を治療する組成物及び方法
HK40070194A (en) Compositions and methods for delivery of therapeutic agents
WO1994025017A1 (fr) PREPARATION PERNASALE A BASE DE threo-3-(3,4-DIHYDROXYPHENYL)SERINE
US20200281950A1 (en) Liposomes for treatment of an autoimmune disease